Syros Pharmaceuticals, Inc. - common stock (SYRS) Social Stream
Syros Pharmaceuticals Inc (SYRS) Price Targets From Analysts
Use the tables below to see what analysts covering Syros Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 142 days, SYRS's average price target has gone up $1.03.
SYRS reports an average of 207.69% for its upside potential over the past 20 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SYRS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
SYRS's average broker recommendation rating improved by 0 over the prior 31 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SYRS as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Syros Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 289.66% of them.
- SYRS has a lower variance in analysts' estimates than -166.64% of all US stocks.
- In terms of how Syros Pharmaceuticals Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 225.13% of that group.
- In terms of how Syros Pharmaceuticals Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 90.45% of that group.
In the Pharmaceutical Products industry, NMTR, SEEL and BTAI are the three stocks most similar to Syros Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is SYRS a Buy, Hold or Sell? See the POWR Ratings now!